Pregnant or breastfeeding women should also speak with their doctor before taking GLP-1 agonists as the safety during pregnancy and lactation is not well established, says Amin
GLP-1based therapy may not be appropriate if you have: -History of medullary thyroid cancer -History of gallbladder disease -History of pancreatitis -Multiple endocrine neoplasia syndrome type 2 (MEN2)
In the hair bulb, IRF4 appears to act on the differentiation and survival of melanocytes
Oldenlandia diffusa (Willd.) Roxb.] Hedyotis diffusa Willd
Dosing is once daily, subcutaneously, with the timing chosen to align with natural lipolytic windows, typically before bed (to coincide with overnight fasting and growth hormone pulses) or first thing in the morning before training and food
Other studies showed significant differences in the sensitivity and specificity of GST-P1 for PC, depending on the testing method (23)